These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12484801)

  • 1. Economic evaluations of varicella vaccination programmes: a review of the literature.
    Thiry N; Beutels P; Van Damme P; Van Doorslaer E
    Pharmacoeconomics; 2003; 21(1):13-38. PubMed ID: 12484801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?
    Soárez PC; Novaes HM; Sartori AM
    Cad Saude Publica; 2009; 25 Suppl 3():S401-14. PubMed ID: 20027388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of varicella vaccination programmes: a review of the literature.
    Hammerschmidt T; Banz K; Wagenpfeil S; Neiss A; Wutzler P
    Pharmacoeconomics; 2004; 22(2):133-6; author reply136-8. PubMed ID: 14731053
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
    Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
    Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness and budget impact of universal varicella vaccination in Russia.
    Marijam A; Safonova E; Scherbakov M; Shpeer E; Van Oorschot D; Rudakova A; Tatochenko V; Briko N
    Hum Vaccin Immunother; 2022 Nov; 18(5):2045152. PubMed ID: 35258445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
    Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of varicella vaccination of healthcare workers.
    Chodick G; Ashkenazi S; Livni G; Lerman Y
    Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
    Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
    BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of varicella vaccination programs: an update of the literature.
    Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
    Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
    Knuf M; Neiss A; Wutzler P
    Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of routine childhood varicella vaccination in Germany.
    Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
    Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of varicella vaccination in Italian adolescents.
    Thiry N; Beutels P; Tancredi F; Romanò L; Zanetti A; Bonanni P; Gabutti G; Van Damme P
    Vaccine; 2004 Sep; 22(27-28):3546-62. PubMed ID: 15315834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.